Not at the moment Hangas, but with the US open for business again they can enter discussions with the FDA regarding the path forward. This will be treated as a matter of urgency from Prima's point of view. If OS is to become the endpoint, and this is more likely to be granted than not in my opinion, then this opens the door to the potential partnering negotiations they have alluded to recently.
Not at the moment Hangas, but with the US open for business...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |